Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MRGPRX4 | Q96LA9 | 7/20 | 0.45 |
| ▸ | AGXT | P21549 | 1/20 | 0.39 |
| ▸ | MAOB | P27338 | 4/20 | 0.38 |
| ▸ | IDO1 | P14902 | 2/20 | 0.37 |
| ▸ | HTR6 | P50406 | 1/20 | 0.37 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.37 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.36 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.36 |
| ▸ | KMO | O15229 | 1/20 | 0.36 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28320546 | 0.84 | MRGPRX4 (0.56) | MRGPRX4AGXTMAOBSLC2A1FFAR1 | |
| SCHEMBL28876729 | 0.82 | MRGPRX4 (0.44) | MRGPRX4AGXTMAOBFFAR1NR4A2 | |
| SCHEMBL28320555 | 0.81 | MRGPRX4 (0.67) | MRGPRX4IDO1 | |
| SCHEMBL28320601 | 0.79 | MRGPRX4 (0.46) | MRGPRX4AGXTMAOBIDO1HTR6 | |
| SCHEMBL16399630 | 0.78 | MRGPRX4 (0.40) | MRGPRX4AGXTMAOBIDO1HTR6 | |
| SCHEMBL5612780 | 0.77 | IDO1 (0.54) | MAOBIDO1KMO | |
| SCHEMBL17969166 | 0.77 | MRGPRX4 (0.39) | MRGPRX4AGXTMAOBFFAR1 | |
| SCHEMBL17969176 | 0.73 | MRGPRX4 (0.43) | MRGPRX4AGXTFFAR1 | |
| SCHEMBL16399492 | 0.72 | POLB (0.47) | MRGPRX4MAOBIDO1NR4A2 | |
| SCHEMBL29624481 | 0.72 | NOS3 (0.44) | KMO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105408325-B | cyanotriazole compounds | 大塚制药株式会社 | 2019-10-22 | — | — | CN | disclosed |